天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
上海百生躍生物科技有限公司 公司信息
公司名稱:
上海百生躍生物科技有限公司
電話:
-
電子郵件:
guojing@bioleaper.com
國籍:
中國
網(wǎng)址:
www.bioleaper.com/
產(chǎn)品總數(shù):
5616
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
公司提供產(chǎn)品列表
Telisotuzumab vedotin
Telisotuzumab Vedotin
1714088-51-3
Cantuzumab ravtansine
Cantuzumab Ravtansine
868747-45-9
Cetuximab-MMAE
Clivatuzumab-MMAE
Codrituzumab-MMAE
Disitamab vedotin
DISITAMAB VEDOTIN (緯迪西妥單抗 )
2136633-23-1
Enapotamab vedotin
1912424-97-5
Glembatumumab vedotin
Ladiratuzumab vedotin
緯拉妥珠單抗
1629760-29-7
Indusatumab vedotin
Indusatumab Vedotin
1514889-12-3
Labetuzumab govitecan
Labetuzumab Govitecan
1469876-18-3
Laprituximab emtansine
Laprituximab Emtansine
1622327-37-0
Lifastuzumab vedotin
Lifastuzumab Vedotin
1401812-88-1
Loncastuximab tesirine
Loncastuximab Tesirine
1879918-31-6
Lorvotuzumab mertansine
Lorvotuzumab Mertansine
1008106-64-6
Lorvotuzumab-MMAE
Mirvetuximab soravtansine
Mirvetuximab Soravtansine
1453084-37-1
Ozuriftamab vedotin
Pinatuzumab vedotin
Pinatuzumab Vedotin
1313706-14-7
Praluzatamab ravtansine
PRALUZATAMAB RAVTANSINE (雷普羅妥單抗 )
Praluzatamab-MMAE
Rosopatamab-MMAE
Sacituzumab govitecan
Satralizumab Linker
1491917-83-9
Serclutamab talirine
SERCLUTAMAB TALIRINE (托思諾妥單抗 )
2140174-56-5
Sirtratumab vedotin
Sirtratumab Vedotin
1824663-83-3
Sofituzumab vedotin
Sofituzumab Vedotin
1418200-58-4
Talacotuzumab-MMAE
Tilvestamab-MMAE
Tisotumab vedotin
Tisotumab Vedotin
1418731-10-8
Trastuzumab deruxtecan
Trastuzumab Deruxtecan
1826843-81-5
Trastuzumab emtansine
曲妥珠單抗-美坦新偶聯(lián)物
1018448-65-1
Tusamitamab-MMAE
Vadastuximab talirine
Vadastuximab Talirine
1436390-64-5
Vorsetuzumab mafodotin
Vorsetuzumab Mafodotin
1165741-01-4
Zilovertamab vedotin
Human NK cell robust expansion kit
人NK細胞高效擴增試劑盒（PBMC細胞起始）
DHG-9140A
一恒鼓風干燥箱DHG-9140A
Firefly Luciferase Reporter Gene Assay Kit
螢火蟲熒光素酶報告基因檢測試劑盒
Buffer
酸性洗滌劑
Human 5HT1B VLP
Human 5HT1D VLP
Human 5HT2B VLP
Human 5HT2C VLP
Human ADGRG7 VLP
Human ADGRL3 VLP
Human ADGRV1 VLP
Human ADORA1 VLP
Human ADRA1A VLP
Human 5HT5B VLP
Human 5HT7R VLP
Human A2AR VLP
Human ACKR1 VLP
Human ACKR2 VLP
Human ADA2B VLP
Human ADCYAP1R1 VLP
Human ADGRA1 VLP
Human ADGRA3 VLP
Human ADGRB1 VLP
Human ADGRD2 VLP
Human ADGRE1 VLP
Human ADGRE5 VLP
Human ADGRF2 VLP
Human ADGRF3 VLP
Human ADGRF4 VLP
Human ADGRF5 VLP
Human ADGRG2 VLP
Human ADGRG3 VLP
Human ADGRG4 VLP
Human ADGRG6 VLP
Human ADGRG5 VLP
Human ADGRG1 VLP
Human ADGRF1 VLP
Human ADGRE3 VLP
Human ADGRE2 VLP
Human ADGRD1 VLP
Human ADGRB3 VLP
Human ADGRB2 VLP
Human ADGRA2 VLP
Human ACKR4 VLP
Human 5HT6R VLP
Human 5HT5A VLP
Human 5HT4R VLP
Human ADORA3 VLP
Human ADORA2B VLP
Human ADGRL4 VLP
Human ADGRL2 VLP
Human ADGRL1 VLP
Human 5HT2A VLP
Human 5HT1F VLP
Human 5HT1E VLP
Human 5HT1A VLP
Tusamitamab ravtansine
Polatuzumab vedotin-piiq
Patritumab deruxtecan
PATRITUMAB DERUXTECAN (德帕瑞妥單抗 )
Murlentamab-MMAE
Mirvetuximab-MMAE
Farletuzumab-MMAE
Enfortumab vedotin-ejfv
Datopotamab deruxtecan
Carotuximab-MMAE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
Copyright 2007? ChemicalBook. All rights reserved.